top of page

RESEARCH IN FOCUS

Explore OPRI’s collection of published research on Oral Corticosteroid (OCS) use

PUBLICATIONS DATABASE

Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study

Pragmatic and Observational Research

18 April 2017

Jaco Voorham, Bernard Vrijens, Job F.M. van Boven, Dermot Ryan, Marc Miravitlles, Lisa M Law, David Price

Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study

Clinical Epidemiology

17 April 2017

Jens Dollerup, Jørgen Vestbo, Tarita Murray-Thomas, Alan Kaplan, Richard J Martin, Emilio Pizzichini, Marcia M M Pizzichini, Annie Burden, Jessica Martin, David Price

Cohort analysis of exacerbation rates in adolescent and adult patients initiating inhaled corticosteroids for asthma: different dose-response profile by particle size

Pulmonary Therapy

12 April 2017

Dirkje Postma, Alan Kaplan, Joan B. Soriano, Jonathon Grigg, Theresa W Guilbert, Willem M.C. van Aalderen, Nicolas Roche, Annie Burden, Elizabeth V Hillyer, Elliot Israel, David Price

Pub Med

A randomized pragmatic trial of changing to and stepping down fluticasone/formoterol in asthma

Journal of Allergy and Clinical Immunology: In Practice

25 March 2017

Omar S. Usmani, Anu Kemppinen, Elizabeth Gardener, Vicky Thomas, Priyanka Raju Konduru, Christina Callan, Andrew McLoughlin, Vanessa Woodhead, Adam Brady, Elizabeth F Juniper, Peter J Barnes, David Price

Comparative effectiveness of step-up therapies in children with asthma prescribed inhaled corticosteroids: a historical cohort study

Journal of Allergy and Clinical Immunology: In Practice

25 March 2017

Clare Murray, Mike Thomas, Kathryn Richardson, David Price, Steve Turner

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma

Pragmatic and Observational Research

22 March 2017

Annie Burden, Nicolas Roche, Cristiana Miglio, Elizabeth V Hillyer, Dirkje Postma, R. Brett McQueen, Ron M.C. Herings, Jetty A. Overbeek, Javaria Mona Khalid, Daniela van Eickels, Joan B. Soriano, David Price

Real-life outcomes for patients with asthma prescribed spacers for use with either extrafine- or fine-particle inhaled corticosteroids

Journal of Allergy and Clinical Immunology: In Practice

18 January 2017

Theresa W Guilbert, Gene Colice, Jonathan Grigg, Willem M.C. van Aalderen, Richard J Martin, Elliot Israel, Dirkje Postma, Nicolas Roche, Wanda Phipatanakul, Elizabeth V Hillyer, Jennifer M. Evans, Myrna B Dolovich, David Price, The Respiratory Effectiveness Group

Identifying risk of future asthma attacks using UK medical record data: a Respiratory Effectiveness Group initiative

Journal of Allergy and Clinical Immunology: In Practice

22 December 2016

John D Blakey, David Price, Emilio Pizzichini, Todor Popov, Borislav D Dimitrov, Dirkje Postma, Lynn K. Josephs, Alan Kaplan, Alberto Papi, Marjan Kerkhof, Elizabeth V Hillyer, Alison Chisholm, Mike Thomas

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis

NPJ Primary Care Respiratory Medicine

3 November 2016

David Price, Marc Miravitlles, Ian Pavord, Mike Thomas, Jadwiga Wedzicha, John Haughney, Katsiaryna Bichel, Daniel West

Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up

Multidisciplinary Respiratory Medicine

2 November 2016

David Price, Job F.M. van Boven, Lisa M Law, Alessandra Cifra, R. Brett McQueen

Inappropriate asthma therapy — a tale of two countries: a parallel population-based cohort study

NPJ Primary Care Respiratory Medicine

13 October 2016

Manon Belhassen, Anjan Nibber, Eric Van Ganse, Dermot Ryan, Carole Langlois, Francis Appiagyei, Derek Skinner, Laurent Laforest, Joan B Soriano, David Price

Asthma-related outcomes in patients initiating extrafine ciclesonide or fine-particle inhaled corticosteroids

Allergy, Asthma & Immunology Research

11 October 2016

Dirkje Postma, Richard Dekhuijzen, Thys van der Molen, Richard J Martin, Willem M.C. van Aalderen, Nicolas Roche, Theresa W Guilbert, Elliot Israel, Daniela van Eickels, Javaria Mona Khalid, Ron M.C. Herings, Jetty A. Overbeek, Cristiana Miglio, Victoria Thomas, Catherine Hutton, Elizabeth V Hillyer, David Price

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

Respiratory Research

23 September 2016

David Halpin, Marjan Kerkhof, Joan B. Soriano, Helga Mikkelsen, David Price

Metabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort study

PLOS ONE

22 September 2016

David Price, Richard Russell, Rafael Mares, Annie Burden, Derek Skinner, Helga Mikkelsen, Cherlyn Ding, Richard Brice, Niels H. Chavannes, Janwillem Kocks, Jeffrey W. Stephens, John Haughney

Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: effect of drug, dose, and device

Respiratory Medicine

22 September 2016

P.N. Richard Dekhuijzen, Maria Batsiou, Leif Bjermer, Sinthia Bosnic-Anticevich, Henry Chrystyn, Alberto Papi, Roberto Rodríguez-Roisin, Monica Fletcher, Lucy Wood, Alessandra Cifra, Joan B. Soriano, David Price

Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease

J Asthma Allergy

26 August 2016

David Price, Anna Rigazio, Mary Buatti Small, Thomas J Ferro

Long-acting β-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids

Journal of Allergy and Clinical Immunology: In Practice

13 July 2016

Steve Turner, Kathryn Richardson, Clare Murray, Mike Thomas, Elizabeth V Hillyer, Annie Burden, David Price, The Respiratory Effectiveness Group

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease

Heart

5 July 2016

Brian Lipworth, Derek Skinner, Graham Devereux, Victoria Thomas, Joanna Ling Zhi Jie, Jessica Martin, Victoria Carter, David Price

UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study

NPJ Primary Care Respiratory Medicine

23 June 2016

David Price, Glenis Scadding, Claus Bachert, Hesham Saleh, Shuaib Nasser, Victoria Carter, Julie von Ziegenweidti, Alice MS Durieux, Dermot Ryan

Excess costs associated with possible misdiagnosis of Alzheimer’s disease among patients with vascular dementia in a UK CPRD population

Journal of Alzheimer’s Disease

22 June 2016

Michael Happich, Noam Y. Kirson, Urvi Desai, Sarah King, Howard G. Birnbaum, Catherine Reed, Mark Belger, Alan Lenox-Smith, David Price

Opri Logo White
An academic research institution striving to improve the lives of patients.
Company
Observational and Pragmatic Research Institute (registered in Singapore) 
Observational Pragmatic Research International (registered in England and Wales)
Follow Us
Contact Us
Email: 
info@opri.sg 
Tel:
(+65) 3105 1489 
Address
OPRI Singapore
22 Sin Ming Lane #06-76, Midview City 573969
OPRI UK
Warren House, Sankence, Aylsham, Norwich NR11 6UN
  • Instagram
  • Threads
  • LinkedIn
  • X
OPRI 2025 All Rights Reserved
bottom of page